CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 18,958	$ 10,513	$ 50,924	$ 23,564
General and administrative	6,978	3,851	20,745	9,103
Total operating expenses	25,936	14,364	71,669	32,667
Loss from operations	(25,936)	(14,364)	(71,669)	(32,667)
Other income (expense):
Interest and other income (expense), net	799	(66)	1,682	(44)
Total other income (expense), net	799	(66)	1,682	(44)
Net loss	$ (25,137)	$ (14,430)	$ (69,987)	$ (32,711)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.80)	$ (9.78)	$ (2.24)	$ (24.18)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.80)	$ (9.78)	$ (2.24)	$ (24.18)
Weighted-average common shares outstanding, basic (in shares)	31,298,052	1,475,170	31,273,612	1,352,721
Weighted-average common shares outstanding, diluted (in shares)	31,298,052	1,475,170	31,273,612	1,352,721
Other comprehensive loss:
Unrealized loss on marketable securities	$ (482)	$ 0	$ (2,747)	$ 0
Total other comprehensive loss	(482)	0	(2,747)	0
Total comprehensive loss	$ (25,619)	$ (14,430)	$ (72,734)	$ (32,711)